Patient Support Tools

AFINITOR^® (everolimus) tools to support your patients with advanced renal cell carcinoma after disease progression on or after sunitinib or sorafenib as they transition to AFINITOR therapy

Patient education and communication are the keys to effective treatment. Novartis remains dedicated to helping your practice by providing valuable and easy-to-use patient education and support materials. Many of the materials below can be downloaded for your patients with advanced renal cell carcinoma.

Understanding Renal Cell Carcinoma Brochure (Coming Soon)
Information to help your patients better understand and manage their disease.

AFINITOR Starter Brochure (Coming Soon)
Easy-to-understand information for patients that reinforces your instructions by explaining what AFINITOR is, what you should know before taking AFINITOR, how to take AFINITOR and common side effects.

AFINITOR Treatment Journey Brochure (Coming Soon)
Comprehensive treatment planning tool filled with resources to help patients get the most out of their AFINITOR therapy.